Yaseen et al. demonstrated a significant increase in IL-31 in SSc serum coupled with the overexpression of its receptor, IL-31RA, in SSc-derived lung fibroblasts, and confirmed the profibrotic effects of IL-31 in mouse lungs [74]. This evidence concerns the gene IL31 and systemic sclerosis.